Posts Tagged ‘press release’

Treatment for Methadone Addiction: Garrettsville Man Faces Drug Charge

Treatment For Methadone Addiction in the News

Treatment For Methadone Addiction: Garrettsville man faces drug charge
Methadone is a schedule II controlled substance that is often used in the treatment of recovering heroin addicts. According to the press release, Spence was on bond from a pending court case in Geauga County where he is facing charges including
Read more on Ravenna Record Courier


Treatment For Methadone Addiction: Stuart medical assistant charged in writing prescriptions for narcotics for
Investigators quoted Rodriquez as saying she has an addiction and used all the drugs herself. In June she sought treatment at an outpatient rehabilitation facility. Since then she hasn't written any more prescriptions, according to the reports.
Read more on TCPalm

Find More Treatment For Methadone Addiction Information…

Methadone on Drug Test: Is Your Patient Abusing or Misusing?

Methadone On Drug Test in the News

Methadone On Drug Test: Is Your Patient Abusing or Misusing?
Require urine drug tests and pill counts within 24 hours of an early refill request. Keep prescription blanks in a place where they can't be stolen and never sign prescription blanks in advance. Assist the pharmacist if he or she calls to verify
Read more on MD News (press release)



Methadone On Drug Test: 'Now I want to be left alone'
His turning point came precisely when he went to the forensic unit, which, he says, is compulsory for any inmate needing methadone (a replacement drug used to wean addicts off heroin). “The conditions at the forensic unit are favourable now but they
Read more on Times of Malta

Find More Methadone On Drug Test Information…

Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – Business Wire (Press Release)

Alcoholism Methadone: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge … – Business Wire (press release)

Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge
Business Wire (press release)
Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of
Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge MarketWatch (press release)

all 13 news articles »

Alcoholism Methadone – Google News

Related Alcoholism Methadone Information…

WellStep Atlanta Announces Fast Track Appointments for Addiction Treatment

Methadone Detox Centers in the News

Methadone Detox Centers: WellStep Atlanta Announces Fast Track Appointments for Addiction Treatment
Suboxone is an opiate agonist which provides a safer and more convenient alternative to methadone for pain pill and heroin treatment. Patients can usually receive Suboxone on the first visit as along as he/she is in mild withdrawal. Opiate detox with
Read more on PR Web (press release)

Related Methadone Detox Centers Information…

Alcoholism Methadone: WellStep Atlanta Announces Fast Track Appointments for Addiction Treatment – PR Web (Press Release)

Alcoholism Methadone: WellStep Atlanta Announces Fast Track Appointments for Addiction Treatment – PR Web (press release)

WellStep Atlanta Announces Fast Track Appointments for Addiction Treatment
PR Web (press release)
pain pill dependence or alcoholism can now obtain appointments as soon as the same or next day. Opiate addiction includes dependence on prescription pain medications including hydrocodone (Vicodin), oxycodone (Percocet and Roxicet) and methadone.

and more »

Alcoholism Methadone – Google News

Related Alcoholism Methadone Information…

Methadone and Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge

Methadone And Alcoholism in the News

Methadone And Alcoholism: Lightlake Therapeutics Inc. Set to Begin Phase II Clinical Trials of Binge
Lightlake recently acquired patents that will allow it to widen its product pipeline to address patients with addictions to opioid painkillers, methadone, cocaine and amphetamine. The Company anticipates launching a development program for each of
Read more on MarketWatch (press release)

More Methadone And Alcoholism Information…